Identifying Rare Subtypes of CD8 T-cells Using Single Cell Reactors

使用单细胞反应器鉴定 CD8 T 细胞的稀有亚型

基本信息

  • 批准号:
    9262845
  • 负责人:
  • 金额:
    $ 27.46万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2016
  • 资助国家:
    美国
  • 起止时间:
    2016-04-15 至 2020-03-31
  • 项目状态:
    已结题

项目摘要

 DESCRIPTION (provided by applicant): Understanding the molecular characteristics of immune cells, such as memory cells, is critical for understanding adaptive immune response. In particular, gaps remain concerning our understanding of whether metabolic changes can drive T cell differentiation (and if so, how), or rather, if these changes are simply by-products of responses to external factors (e.g., cytokines) encountered during the course of differentiation. Further, it remains unclear whether there exists a direct causal relationship between modulation of the fatty acid metabolizing machinery and the critical cell fate decision(s) dictating the transition from an effector to a memory cell, and whether metabolic states in individual cells can be correlated with larger population dynamics. We seek to identify a panel of molecular markers will allow future functional testing and identification of fate decision pathways for this criticaly important cell type. To overcome the limitations of single cell molecular profiling and standard metabolic assays, we will develop a novel microfluidics device that will enable rapid single cell metabolic profiling and sorting coupled to single cell transcriptome profiling. Utilizing this devie, we will isolate rare subpopulations of CD8 T cells by their metabolic signatures and identify molecular markers for each subpopulation. In Aim 1, we will develop a microfluidics system for rapid single cell metabolic profiling and sorting. Specifically, a high-speed fluorocarbon (FC) oil droplet cell encapsulating microfluidics device coupled to metabolic functional dye probes and high-content detector sorting system will be developed. The device will be optimized for speed, capture efficiency, cell viability, high-speed detection, and sorting. In Aim 2, we will identify molecular markers in sub-population of CD8 T cells during response program using single cell RNASeq. To achieve this aim, we will couple the microfluidics device with select functional dyes to characterize individual cell's metabolic states. The profiles of the metabolic readouts will be analyzed by computational methods to identify distinct subpopulations. These metabolic signatures will be used to gate the cells by the microfluidics device in a sorting mode and the resulting subpopulations of cells will be analyzed by single cell RNASeq to identify molecular markers for each subtype. The results of this study will lead to future studies on the role of identified molecules in T cell response dynamics. Understanding the molecular basis of T cell functional subtypes will not only enhance understanding of our body's response to diseases, it will lead to translational applications in areas such as cancer immune-therapy.
 描述(由申请人提供):了解免疫细胞(如记忆细胞)的分子特征对于了解适应性免疫应答至关重要。特别是,关于我们对代谢变化是否可以驱动T细胞分化(如果是,如何)的理解,或者更确切地说,如果这些变化只是对外部因素(例如,细胞因子)。此外,尚不清楚脂肪酸代谢机制的调节与决定从效应细胞向记忆细胞转变的关键细胞命运决定之间是否存在直接因果关系,以及个体细胞中的代谢状态是否与更大的群体动态相关。我们试图确定一组分子标记物,这将使未来的功能测试和确定这种至关重要的细胞类型的命运决定途径。为了克服单细胞分子分析和标准代谢测定的局限性,我们将开发一种新型的微流体装置,该装置将使快速单细胞代谢分析和分选与单细胞转录组分析相结合。利用该装置,我们将通过其代谢特征分离罕见的CD8 T细胞亚群,并确定每个亚群的分子标记。在目标1中,我们将开发一种用于快速单细胞代谢分析和分选的微流体系统。具体地,高速氟碳(FC)油 将开发液滴细胞封装微流体装置,其耦合到代谢功能染料探针和高含量检测器分选系统。该设备将针对速度、捕获效率、细胞活力、高速检测和分选进行优化。在目标2中,我们将使用单细胞RNASeq在应答程序期间鉴定CD8 T细胞亚群中的分子标志物。为了实现这一目标,我们将把微流体装置与选择的功能染料耦合,以表征单个细胞的代谢状态。将通过计算方法分析代谢读数的特征,以识别不同的亚群。这些代谢特征将用于通过微流体装置以分选模式门控细胞,并且将通过单细胞RNASeq分析所得细胞亚群以鉴定每种亚型的分子标记物。这项研究的结果将导致未来的研究所确定的分子在T细胞反应动力学的作用。了解T细胞功能亚型的分子基础不仅会增强对我们身体对疾病反应的理解,还将导致癌症免疫治疗等领域的转化应用。

项目成果

期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

YONGWON CHOI其他文献

YONGWON CHOI的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('YONGWON CHOI', 18)}}的其他基金

IgSF11 Signaling Controls Osteoclast Maturation and Pathogenic Bone Loss
IgSF11 信号传导控制破骨细胞成熟和致病性骨质流失
  • 批准号:
    10544787
  • 财政年份:
    2022
  • 资助金额:
    $ 27.46万
  • 项目类别:
IgSF11 Signaling Controls Osteoclast Maturation and Pathogenic Bone Loss
IgSF11 信号传导控制破骨细胞成熟和致病性骨质流失
  • 批准号:
    10337682
  • 财政年份:
    2022
  • 资助金额:
    $ 27.46万
  • 项目类别:
Protocadherin 7 and Osteoclast Maturation
原钙粘蛋白 7 和破骨细胞成熟
  • 批准号:
    10206010
  • 财政年份:
    2020
  • 资助金额:
    $ 27.46万
  • 项目类别:
Protocadherin 7 and Osteoclast Maturation
原钙粘蛋白 7 和破骨细胞成熟
  • 批准号:
    10430027
  • 财政年份:
    2020
  • 资助金额:
    $ 27.46万
  • 项目类别:
Protocadherin 7 and Osteoclast Maturation
原钙粘蛋白 7 和破骨细胞成熟
  • 批准号:
    10027049
  • 财政年份:
    2020
  • 资助金额:
    $ 27.46万
  • 项目类别:
Regulation of T cell responses to oral antigens
T 细胞对口腔抗原反应的调节
  • 批准号:
    9306661
  • 财政年份:
    2017
  • 资助金额:
    $ 27.46万
  • 项目类别:
Dendritic Cell-Mediated Oral Antigen Tolerance and the Lung
树突状细胞介导的口腔抗原耐受和肺
  • 批准号:
    9238657
  • 财政年份:
    2016
  • 资助金额:
    $ 27.46万
  • 项目类别:
Cell Adhesion Regulation of Osteoclast Maturation
破骨细胞成熟的细胞粘附调节
  • 批准号:
    9899199
  • 财政年份:
    2016
  • 资助金额:
    $ 27.46万
  • 项目类别:
Dendritic Cell-Mediated Oral Antigen Tolerance and the Lung
树突状细胞介导的口腔抗原耐受和肺
  • 批准号:
    9086712
  • 财政年份:
    2016
  • 资助金额:
    $ 27.46万
  • 项目类别:
Identifying Rare Subtypes of CD8 T-cells Using Single Cell Reactors
使用单细胞反应器鉴定 CD8 T 细胞的稀有亚型
  • 批准号:
    9086041
  • 财政年份:
    2016
  • 资助金额:
    $ 27.46万
  • 项目类别:

相似海外基金

WELL-CALF: optimising accuracy for commercial adoption
WELL-CALF:优化商业采用的准确性
  • 批准号:
    10093543
  • 财政年份:
    2024
  • 资助金额:
    $ 27.46万
  • 项目类别:
    Collaborative R&D
Investigating the Adoption, Actual Usage, and Outcomes of Enterprise Collaboration Systems in Remote Work Settings.
调查远程工作环境中企业协作系统的采用、实际使用和结果。
  • 批准号:
    24K16436
  • 财政年份:
    2024
  • 资助金额:
    $ 27.46万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Unraveling the Dynamics of International Accounting: Exploring the Impact of IFRS Adoption on Firms' Financial Reporting and Business Strategies
揭示国际会计的动态:探索采用 IFRS 对公司财务报告和业务战略的影响
  • 批准号:
    24K16488
  • 财政年份:
    2024
  • 资助金额:
    $ 27.46万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 27.46万
  • 项目类别:
    EU-Funded
Assessing the Coordination of Electric Vehicle Adoption on Urban Energy Transition: A Geospatial Machine Learning Framework
评估电动汽车采用对城市能源转型的协调:地理空间机器学习框架
  • 批准号:
    24K20973
  • 财政年份:
    2024
  • 资助金额:
    $ 27.46万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 27.46万
  • 项目类别:
    EU-Funded
Our focus for this project is accelerating the development and adoption of resource efficient solutions like fashion rental through technological advancement, addressing longer in use and reuse
我们该项目的重点是通过技术进步加快时装租赁等资源高效解决方案的开发和采用,解决更长的使用和重复使用问题
  • 批准号:
    10075502
  • 财政年份:
    2023
  • 资助金额:
    $ 27.46万
  • 项目类别:
    Grant for R&D
Engage2innovate – Enhancing security solution design, adoption and impact through effective engagement and social innovation (E2i)
Engage2innovate — 通过有效参与和社会创新增强安全解决方案的设计、采用和影响 (E2i)
  • 批准号:
    10089082
  • 财政年份:
    2023
  • 资助金额:
    $ 27.46万
  • 项目类别:
    EU-Funded
De-Adoption Beta-Blockers in patients with stable ischemic heart disease without REduced LV ejection fraction, ongoing Ischemia, or Arrhythmias: a randomized Trial with blinded Endpoints (ABbreviate)
在没有左心室射血分数降低、持续性缺血或心律失常的稳定型缺血性心脏病患者中停用β受体阻滞剂:一项盲法终点随机试验(ABbreviate)
  • 批准号:
    481560
  • 财政年份:
    2023
  • 资助金额:
    $ 27.46万
  • 项目类别:
    Operating Grants
Collaborative Research: SCIPE: CyberInfrastructure Professionals InnoVating and brOadening the adoption of advanced Technologies (CI PIVOT)
合作研究:SCIPE:网络基础设施专业人员创新和扩大先进技术的采用 (CI PIVOT)
  • 批准号:
    2321091
  • 财政年份:
    2023
  • 资助金额:
    $ 27.46万
  • 项目类别:
    Standard Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了